Promising Prospects Expected in 2026 for GE HealthCare Technologies (GEHC)

Group 1 - GE HealthCare Technologies (NASDAQ:GEHC) is recognized as one of the top 12 Medical Devices stocks to invest in according to hedge funds [1] - David Roman from Goldman Sachs has reiterated a Buy rating for GE HealthCare Technologies and raised the price target from $86 to $98, indicating a potential upside of nearly 24% for investors [1] - Vijay Kumar of Evercore ISI has maintained an Outperform rating on GE HealthCare Technologies, with an upward revision of the price target from $92 to $95, suggesting an anticipated upside of nearly 20% [3] Group 2 - The company operates in the pharmaceutical diagnostics and medical technology sectors, focusing on precision care through the development and marketing of products and services used in patient diagnosis, treatment, and monitoring [5] - GE HealthCare Technologies is structured into four segments: Advanced Visualization Solutions (AVS), Imaging, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx) [5] - Kumar expects 2026 to present interesting prospects for the medical technology space, driven by strong capital expenditure trends and recovery indicators in China [4]